Third‐generation sequencing identified two rare α‐chain variants leading to hemoglobin variants in Chinese population
Molecular Genetics & Genomic Medicine · 2024
DOI: 10.1002/mgg3.2365 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Genetics & Genomic Medicine, 2024. Verfasst von Jianlong Zhuang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Prenatal Diagnosis Center, Quanzhou Women's and Children's Hospital, Quanzhou, Fujian, China. Hauptthemen laut MEDLINE: beta-Thalassemia, Thalassemia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Huaqiao University Joint of Hospital and University Innovation Project, Fujian Provincial Key Laboratory of Prenatal Diagnosis and Birth Defects open project.
Abstract (Originalsprache)
Background
Rare and novel variants of HBA1/2 and HBB genes resulting in thalassemia and hemoglobin (Hb) variants have been increasingly identified. Our goal was to identify two rare Hb variants in Chinese population using third‐generation sequencing (TGS) technology.
Methods
Enrolled in this study were two Chinese families from Fujian Province. Hematological screening was conducted using routine blood analysis and Hb capillary electrophoresis analysis. Routine thalassemia gene testing was carried out to detect the common mutations of α‐ and β‐thalassemia in Chinese population. Rare or novel α‐ and β‐globin gene variants were further investigated by TGS.
Results
The proband of family 1 was a female aged 32, with decreased levels of mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), Hb A2, and abnormal Hb bands in zone 5 and zone 12. No common thalassemia mutations were detected by routine thalassemia analysis, while a rare α‐globin gene variant Hb Jilin [α139(HC1)Lys>Gln (AAA>CAA); HBA2:c.418A>C] was identified by TGS. Subsequent pedigree analysis showed that the proband's son also harbored the Hb Jilin variant with slightly low levels of MCH, Hb A2, and abnormal Hb bands. The proband of family 2 was a male at 41 years of age, exhibiting normal MCV and MCH, but a low level of Hb A2 and an abnormal Hb band in zone 12 without any common α‐ and β‐thalassemia mutations. The subsequent TGS detection demonstrated a rare Hb Beijing [α16(A14)Lys>Asn (AAG>AAT); HBA2:c.51G>T] variant in HBA2 gene.
Conclusion
In this study, for the first time, we present two rare Hb variants of Hb Jilin and Hb Beijing in Fujian Province, Southeast China, using TGS technology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Prenatal Diagnosis Center, Quanzhou Women's and Children's Hospital, Quanzhou, Fujian, China.
- Department of Ultrasound, Quanzhou Women's and Children's Hospital, Quanzhou, Fujian, China.
- Department of TGS Research and Development, Berry Genomics Corporation, Beijing, China.
- Department of Children Health Care, Quanzhou Women's and Children's Hospital, Quanzhou, China.
- Department of Neurology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China.
ORCID-Profile: Jianlong Zhuang
Förderung
- Huaqiao University Joint of Hospital and University Innovation Project
- Fujian Provincial Key Laboratory of Prenatal Diagnosis and Birth Defects open project
Zitieren
APA
Zhuang, J., Jiang, Y., Chen, Y., Mao, A., Chen, J., & Chen, C. (2024). Third‐generation sequencing identified two rare α‐chain variants leading to hemoglobin variants in Chinese population. Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.2365
Vancouver
Zhuang J, Jiang Y, Chen Y, Mao A, Chen J, Chen C. Third‐generation sequencing identified two rare α‐chain variants leading to hemoglobin variants in Chinese population. Molecular Genetics & Genomic Medicine. 2024. doi:10.1002/mgg3.2365
BibTeX
@article{Zhuang2024,
author = {Zhuang, Jianlong and Jiang, Yuying and Chen, Yu'e and Mao, Aiping and Chen, Junwei and Chen, Chunnuan},
title = {Third‐generation sequencing identified two rare α‐chain variants leading to hemoglobin variants in Chinese population},
journal = {Molecular Genetics & Genomic Medicine},
year = {2024},
doi = {10.1002/mgg3.2365}
}
EUVIMED